PubMed · 2014 · 42 citations · 8 references
Open access
Antifibrotic TherapyInflammatory Lung DiseaseLung InflammationImmunologyImmune RegulationPathologyImmune SystemInflammationDex TreatmentPulmonary PharmacologyFibrosisBleomycin-induced Lung FibrosisChronic InflammationPulmonary FibrosisJak-stat PathwayPulmonary DiseaseMice ModelCytokineMedicineSevere Pulmonary Fibrosis
In order to find the possible mechanism of Dexamethasone (Dex) during curing fibrosis, the bleomycin (BLM)-induced mice model was used. After fibrosis were induced by BLM, histopathological evaluation and RT-PCR were employed to detect the expression of TGF-β1, Smad3 and STAT1. It was found that BLM promoted the development of inflammation, leading to severe pulmonary fibrosis with the increasing of TGF-β1, Smad3 and STAT1. After Dex treatment, the expression of TGF-β1, Smad3 and STAT1 showed a little higher with alleviation of the fibrosis. Thus it is concluded that there is a possible pathway of mouse pulmonary fibrosis model through TGF-β, Smad3 and JAK-STAT pathway.
8
The pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Ian Y. R. Adamson, D. H. Bowden · PubMed · 1974 · 484 citations · Full text
Bleomycin-induced interstitial pneumonia in dogs
Robert W. Fleischman, John Baker, George R. Thompson et al. · Thorax · 1971 · 138 citations · Full text